Macquarie maintained an underperform rating on Zydus Life with a target price of Rs 490. The Q2FY24 results were a mixed bag.
Citi downgrades US stocks to ‘neutral’ as AI sell-off, regulatory risks mount
Citigroup strategists have downgraded US equities to neutral due to ongoing market volatility and regulatory concerns. This decision follows a significant sell-off that erased $3